Desquamative interstitial pneumonia
Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
At the time the article was last revised Henry Knipe had the following disclosures:
- Integral Diagnostics, Shareholder (ongoing)
- Micro-X Ltd, Shareholder (ongoing)
These were assessed during peer review and were determined to not be relevant to the changes that were made.View Henry Knipe's current disclosures
Desquamative interstitial pneumonia (DIP) is an interstitial pneumonia closely related to and thought to represent the end stage of respiratory bronchiolitis interstitial lung disease (RB-ILD). It is associated with heavy smoking.
DIP is considered one of the rarest of idiopathic interstitial pneumonias 11. There is a recognized male predilection (M:F = 2:1).
Presentation tends to be in middle age (30-60 years of age) with progressive shortness of breath and chronic cough 4.
The vast majority of patients are heavy smokers (90%) with an average smoking history of 18 pack-years. However, other predisposing factors include:
infection, e.g. HIV 4
toxin, occupational or environmental exposure, e.g. asbestos 6,7
Pulmonary function tests
Pulmonary restriction is usually absent or slight, although diffusion is impaired in most patients 9.
Despite differences in the CT appearance of RB-ILD and DIP, imaging findings may overlap and may be indistinguishable from each other. To improve diagnostic accuracy, lung biopsy is required in all cases of suspected RB-ILD or DIP ref.
DIP's name is misleading as no desquamation of alveolar epithelium is present, but rather the cells that fill the alveoli are pigment-laden macrophages. This is more pronounced than in RB-ILD.
may show bilateral interstitial opacities 8: they may have a greater predilection for the lower-lung zones and, sometimes, peripheral predominance 9
has been classically described as one of triangular-shaped regions of increased density radiating from the hilar regions to the periphery; although, this is seen in only a minority of cases 10
DIP is usually characterized by diffuse ground-glass opacities (sometimes has a granular or nodular texture), which correlate histologically with the spatially homogeneous intra-alveolar accumulation of macrophages and thickening of alveolar septa:
bilateral and symmetric (86%) 7
basal and peripheral (60%)
diffuse (20%) 4
Other frequent CT findings include spatially limited, irregular linear opacities and small cystic spaces, which are indicative of fibrotic change (50% of patients 7).
Honeycombing may be seen in less than one-third of cases, and if present tends to be usually peripheral and limited in extent 9.
Treatment and prognosis
With smoking cessation and corticosteroid therapy, the prognosis is good. The overall prognosis of has been described as being significantly better than that of fibrotic non-specific interstitial pneumonia 11. Nevertheless, progressive disease with eventual death can occur, notably in patients with continued cigarette smoking.
For diffuse ground glass changes on CT consider the differential for ground glass opacities.
- 1. Attili AK, Kazerooni EA, Gross BH et-al. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics. 28 (5): 1383-96. doi:10.1148/rg.285075223 - Pubmed citation
- 2. Miller WT, Shah RM. Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations. AJR Am J Roentgenol. 2005;184 (2): 613-22. AJR Am J Roentgenol (full text) - Pubmed citation
- 3. Heyneman LE, Ward S, Lynch DA et-al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol. 1999;173 (6): 1617-22. AJR Am J Roentgenol (abstract) - Pubmed citation
- 4. Naidich DP, Srichai MB, Krinsky GA. Computed tomography and magnetic resonance of the thorax. Lippincott Williams & Wilkins. (2007) ISBN:0781757657. Read it at Google Books - Find it at Amazon
- 5. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 1998;157 (4 Pt 1): 1301-15. Am. J. Respir. Crit. Care Med. (full text) - Pubmed citation
- 6. Freed JA, Miller A, Gordon RE et-al. Desquamative interstitial pneumonia associated with chrysotile asbestos fibres. Br J Ind Med. 1991;48 (5): 332-7. Free text at pubmed - Pubmed citation
- 7. Hartman TE, Primack SL, Swensen SJ et-al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology. 1993;187 (3): 787-90. Radiology (abstract) - Pubmed citation
- 8. Ryu JH, Myers JL, Capizzi SA et-al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005;127 (1): 178-84. doi:10.1378/chest.127.1.178 - Pubmed citation
- 9. Godbert B, Wissler MP, Vignaud JM. Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology. Eur Respir Rev. 2013;22 (128): 117-23. doi:10.1183/09059180.00005812 - Pubmed citation
- 10. King MB, Jessurun J, Hertz MI. Recurrence of desquamative interstitial pneumonia after lung transplantation. Am. J. Respir. Crit. Care Med. 1997;156 (6): 2003-5. doi:10.1164/ajrccm.156.6.9703001 - Pubmed citation
- 11. Tazelaar HD, Wright JL, Churg A. Desquamative interstitial pneumonia. Histopathology. 2011;58 (4): 509-16. doi:10.1111/j.1365-2559.2010.03649.x - Pubmed citation
- 13. Kroll, Ryan R, Flood, Diane A, Srigley, John. Desquamative Interstitial Pneumonitis in a Healthy Non-Smoker: A Rare Diagnosis. (2014) Canadian Respiratory Journal. 21 (2): 86. doi:10.1155/2014/803708 - Pubmed
- 14. Merel E. Hellemons, Catharina C. Moor, Jan von der Thüsen, Mariska Rossius, Arlette Odink, Laila Haugen Thorgersen, Johny Verschakelen, Wim Wuyts, Marlies S. Wijsenbeek, Elisabeth Bendstrup. Desquamative interstitial pneumonia: a systematic review of its features and outcomes. (2020) European Respiratory Review. doi:10.1183/16000617.0181-2019 - Pubmed